This article is more than 5 years old. Information may no longer be current.

Lumenis photocoagulation laser receives FDA clearance

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

SANTA CLARA, Calif. — A photocoagulation laser system for the treatment of age-related macular degeneration, diabetic retinopathy and other retinal diseases has received marketing clearance in the United States.

The Novus Varia photocoagulation laser system (Lumenis) offers green, yellow and red wavelengths in one standard platform, according to a company news release. Physicians can switch among the wavelengths and power settings to penetrate mild vitreous opacity, sclerotic lens or mild vitreous hemorrhage, the release states.